基线人口统计学对ACS患者血脂的影响:揭示隐藏的驱动因素

IF 3.6 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Monika Bhandari MD, Pravesh Vishwakarma MD, Abhishek Singh MD, Rishi Sethi MD, Jyoti Bajpai MD, Akshyaya Pradhan MD
{"title":"基线人口统计学对ACS患者血脂的影响:揭示隐藏的驱动因素","authors":"Monika Bhandari MD,&nbsp;Pravesh Vishwakarma MD,&nbsp;Abhishek Singh MD,&nbsp;Rishi Sethi MD,&nbsp;Jyoti Bajpai MD,&nbsp;Akshyaya Pradhan MD","doi":"10.1016/j.jacl.2025.04.091","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/Synopsis</h3><div>Acute coronary syndromes (ACS) remain a major global cardiovascular challenge with evolving treatment paradigms. Despite advances in management, the influence of baseline patient demographics on lipid profiles at presentation has received limited attention.</div></div><div><h3>Objective/Purpose</h3><div>This study explores the associations between demographic factors and lipid profile in ACS patients.</div></div><div><h3>Methods</h3><div>In this single-center, retrospective study, we analyzed data from 1,671 consecutive ACS patients admitted for treatment. Baseline demographics—including age, gender, comorbidities (diabetes mellitus and hypertension), and smoking status—were examined in relation to lipid profile components (total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglycerides) measured upon admission. Additionally, among the 853 patients who underwent coronary angiography, we evaluated the relationship between lipid levels and angiographic severity. Clinical presentations were categorized as ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), or unstable angina.</div></div><div><h3>Results</h3><div>The mean age of the cohort was 56.29 ± 11.73 years, with a male predominance (81.5%). Patients under 40 years exhibited significantly higher mean levels of total cholesterol, LDL-C, and triglycerides compared to those between 41 and 60 years and over 60 years (p = 0.002, 0.001, and &lt; 0.001, respectively), potentially reflecting the more frequent use of lipid-lowering therapies in older patients. Females had higher levels of total cholesterol and HDL-C than males (p = 0.027 and &lt; 0.001, respectively). Diabetic patients (n = 475) and hypertensive patients (n = 538) demonstrated lower LDL-C levels relative to non-diabetics and non-hypertensive individuals (p &lt; 0.001), suggesting more aggressive lipid management and adherence to lifestyle modifications in these populations. Smokers (n = 799) presented with elevated total cholesterol and LDL-C levels compared to non-smokers (p = 0.002 and 0.02, respectively). In the subset undergoing coronary angiography, significant correlations emerged between angiographic severity and both total cholesterol and LDL-C levels (p = 0.005). Moreover, patients presenting with STEMI (68.7% of the cohort) had markedly higher total cholesterol and LDL-C levels compared to those with NSTEMI or unstable angina (p &lt; 0.001).</div></div><div><h3>Conclusions</h3><div>In this South Asian cohort of ACS patients, baseline lipid profiles varied significantly with age, gender, comorbidities, smoking status, angiographic findings, and clinical presentation. These findings highlight the importance of considering demographic factors in risk stratification and tailoring lipid management strategies to improve outcomes in ACS patients.</div></div>","PeriodicalId":15392,"journal":{"name":"Journal of clinical lipidology","volume":"19 3","pages":"Pages e65-e66"},"PeriodicalIF":3.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of baseline demographics on lipid profile in patients with ACS: Unmasking hidden drivers\",\"authors\":\"Monika Bhandari MD,&nbsp;Pravesh Vishwakarma MD,&nbsp;Abhishek Singh MD,&nbsp;Rishi Sethi MD,&nbsp;Jyoti Bajpai MD,&nbsp;Akshyaya Pradhan MD\",\"doi\":\"10.1016/j.jacl.2025.04.091\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background/Synopsis</h3><div>Acute coronary syndromes (ACS) remain a major global cardiovascular challenge with evolving treatment paradigms. Despite advances in management, the influence of baseline patient demographics on lipid profiles at presentation has received limited attention.</div></div><div><h3>Objective/Purpose</h3><div>This study explores the associations between demographic factors and lipid profile in ACS patients.</div></div><div><h3>Methods</h3><div>In this single-center, retrospective study, we analyzed data from 1,671 consecutive ACS patients admitted for treatment. Baseline demographics—including age, gender, comorbidities (diabetes mellitus and hypertension), and smoking status—were examined in relation to lipid profile components (total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglycerides) measured upon admission. Additionally, among the 853 patients who underwent coronary angiography, we evaluated the relationship between lipid levels and angiographic severity. Clinical presentations were categorized as ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), or unstable angina.</div></div><div><h3>Results</h3><div>The mean age of the cohort was 56.29 ± 11.73 years, with a male predominance (81.5%). Patients under 40 years exhibited significantly higher mean levels of total cholesterol, LDL-C, and triglycerides compared to those between 41 and 60 years and over 60 years (p = 0.002, 0.001, and &lt; 0.001, respectively), potentially reflecting the more frequent use of lipid-lowering therapies in older patients. Females had higher levels of total cholesterol and HDL-C than males (p = 0.027 and &lt; 0.001, respectively). Diabetic patients (n = 475) and hypertensive patients (n = 538) demonstrated lower LDL-C levels relative to non-diabetics and non-hypertensive individuals (p &lt; 0.001), suggesting more aggressive lipid management and adherence to lifestyle modifications in these populations. Smokers (n = 799) presented with elevated total cholesterol and LDL-C levels compared to non-smokers (p = 0.002 and 0.02, respectively). In the subset undergoing coronary angiography, significant correlations emerged between angiographic severity and both total cholesterol and LDL-C levels (p = 0.005). Moreover, patients presenting with STEMI (68.7% of the cohort) had markedly higher total cholesterol and LDL-C levels compared to those with NSTEMI or unstable angina (p &lt; 0.001).</div></div><div><h3>Conclusions</h3><div>In this South Asian cohort of ACS patients, baseline lipid profiles varied significantly with age, gender, comorbidities, smoking status, angiographic findings, and clinical presentation. These findings highlight the importance of considering demographic factors in risk stratification and tailoring lipid management strategies to improve outcomes in ACS patients.</div></div>\",\"PeriodicalId\":15392,\"journal\":{\"name\":\"Journal of clinical lipidology\",\"volume\":\"19 3\",\"pages\":\"Pages e65-e66\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical lipidology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1933287425001679\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical lipidology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1933287425001679","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景/简介急性冠状动脉综合征(ACS)仍然是一个主要的全球心血管挑战,治疗模式不断发展。尽管在管理方面取得了进展,但基线患者人口统计学对呈现时血脂谱的影响受到的关注有限。目的/目的探讨ACS患者的人口统计学因素与血脂的关系。方法在这项单中心回顾性研究中,我们分析了1,671例连续入院治疗的ACS患者的数据。基线人口统计数据——包括年龄、性别、合并症(糖尿病和高血压)和吸烟状况——与入院时测量的脂质成分(总胆固醇、低密度脂蛋白胆固醇[LDL-C]、高密度脂蛋白胆固醇[HDL-C]和甘油三酯)相关。此外,在接受冠状动脉造影的853例患者中,我们评估了血脂水平与血管造影严重程度之间的关系。临床表现分为st段抬高型心肌梗死(STEMI)、非st段抬高型心肌梗死(NSTEMI)和不稳定型心绞痛。结果患者平均年龄56.29±11.73岁,男性占81.5%。40岁以下患者的总胆固醇、LDL-C和甘油三酯平均水平明显高于41 - 60岁和60岁以上的患者(p = 0.002,0.001和<;0.001),这可能反映了老年患者更频繁地使用降脂疗法。女性的总胆固醇和HDL-C水平高于男性(p = 0.027和<;分别为0.001)。糖尿病患者(n = 475)和高血压患者(n = 538)LDL-C水平低于非糖尿病和非高血压患者(p <;0.001),表明在这些人群中更积极的脂质管理和坚持改变生活方式。吸烟者(n = 799)与不吸烟者相比,总胆固醇和LDL-C水平升高(p = 0.002和0.02)。在接受冠状动脉造影的亚群中,血管造影严重程度与总胆固醇和LDL-C水平之间存在显著相关性(p = 0.005)。此外,STEMI患者(68.7%)的总胆固醇和LDL-C水平明显高于非STEMI或不稳定型心绞痛患者(p <;0.001)。结论:在南亚ACS患者队列中,基线脂质谱随年龄、性别、合并症、吸烟状况、血管造影结果和临床表现而显著变化。这些发现强调了在危险分层和调整脂质管理策略中考虑人口因素以改善ACS患者预后的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact of baseline demographics on lipid profile in patients with ACS: Unmasking hidden drivers

Background/Synopsis

Acute coronary syndromes (ACS) remain a major global cardiovascular challenge with evolving treatment paradigms. Despite advances in management, the influence of baseline patient demographics on lipid profiles at presentation has received limited attention.

Objective/Purpose

This study explores the associations between demographic factors and lipid profile in ACS patients.

Methods

In this single-center, retrospective study, we analyzed data from 1,671 consecutive ACS patients admitted for treatment. Baseline demographics—including age, gender, comorbidities (diabetes mellitus and hypertension), and smoking status—were examined in relation to lipid profile components (total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglycerides) measured upon admission. Additionally, among the 853 patients who underwent coronary angiography, we evaluated the relationship between lipid levels and angiographic severity. Clinical presentations were categorized as ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), or unstable angina.

Results

The mean age of the cohort was 56.29 ± 11.73 years, with a male predominance (81.5%). Patients under 40 years exhibited significantly higher mean levels of total cholesterol, LDL-C, and triglycerides compared to those between 41 and 60 years and over 60 years (p = 0.002, 0.001, and < 0.001, respectively), potentially reflecting the more frequent use of lipid-lowering therapies in older patients. Females had higher levels of total cholesterol and HDL-C than males (p = 0.027 and < 0.001, respectively). Diabetic patients (n = 475) and hypertensive patients (n = 538) demonstrated lower LDL-C levels relative to non-diabetics and non-hypertensive individuals (p < 0.001), suggesting more aggressive lipid management and adherence to lifestyle modifications in these populations. Smokers (n = 799) presented with elevated total cholesterol and LDL-C levels compared to non-smokers (p = 0.002 and 0.02, respectively). In the subset undergoing coronary angiography, significant correlations emerged between angiographic severity and both total cholesterol and LDL-C levels (p = 0.005). Moreover, patients presenting with STEMI (68.7% of the cohort) had markedly higher total cholesterol and LDL-C levels compared to those with NSTEMI or unstable angina (p < 0.001).

Conclusions

In this South Asian cohort of ACS patients, baseline lipid profiles varied significantly with age, gender, comorbidities, smoking status, angiographic findings, and clinical presentation. These findings highlight the importance of considering demographic factors in risk stratification and tailoring lipid management strategies to improve outcomes in ACS patients.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.00
自引率
6.80%
发文量
209
审稿时长
49 days
期刊介绍: Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. Sections of Journal of clinical lipidology will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信